Citramalic Acid

Your urine carries faint chemical signatures of what is happening inside your gut. Citramalic acid is one of those signatures. It is a small organic acid that researchers describe as being produced mainly by certain microbes living in your digestive tract rather than by your own cells, which is why some clinicians look at it as a clue about microbial activity that standard stool and blood tests do not capture.

This is a research-grade marker, not an established clinical test with universal cutoffs. Reading it well means treating it as one input in a wider picture, paying more attention to your trend than to any single number, and pairing it with other markers and your symptoms.

What Citramalic Reflects

Citramalic acid (also called citramalate) is structurally close to malate, a molecule your own cells use heavily in energy production. The version measured in urine, however, has been associated in the literature with microbial sources, particularly yeasts and certain anaerobic bacteria. When unusually high amounts appear in urine, the working hypothesis is that microbes producing or releasing this acid are more active or more numerous than usual in your gut.

Being precise here matters. The lab is measuring how much citramalic acid is leaving your body in urine, reported relative to creatinine to adjust for how concentrated your sample is. The test is not directly counting microbes, identifying a species, or measuring an enzyme. It is reading a chemical footprint and inferring what may be upstream.

Why It Is Studied

Citramalic acid is included on organic acid testing panels because it sits at an interesting intersection of human biology and microbiology. Reference values for urinary citramalic in healthy adults have been published, based on measurements in 122 healthy adults using a lab technique that separates and identifies small molecules, giving labs a starting point for what a typical level looks like.

Broader work on urinary organic acids has shown that this class of testing can flag inherited metabolic conditions and shift patterns in neurodevelopmental conditions. In a study of 2,483 children evaluated for global developmental delay or intellectual disability, urine organic acid profiling identified differential metabolites associated with these conditions, and a separate study used urine organic acids combined with machine learning to distinguish 220 children with autism-spectrum disorder from controls. Citramalic acid is one of many organic acids that can appear in such profiles, though these studies focused on patterns across multiple acids rather than on citramalic alone.

What This Test Can and Cannot Tell You

Citramalic acid is a research-grade marker. That means there are no universally agreed upon cutpoints, no large outcome studies linking specific urinary levels to disease risk, and no clinical guidelines telling doctors what to do at a given number. It can be a useful clue in a broader workup, but it should not be the sole basis for a diagnosis or a treatment decision.

One nuance matters a lot. Most published findings linking citramalic to disease come from samples other than urine. In early-stage amyotrophic lateral sclerosis (a progressive nerve disease, ALS), citramalate was the only metabolite that distinguished patients from controls in both serum and muscle tissue, with the authors describing it as a candidate biomarker tied to disturbed energy metabolism. In general chronic periodontitis (gum disease), citramalic acid in gingival crevicular fluid (the fluid that bathes the gum line) was part of a multi-metabolite signature, and combining citramalic with another metabolite produced strong discrimination between patients and healthy controls. Neither finding was made in urine. They are biologically interesting but cannot be directly translated to what a urine citramalic value means for you.

The Microbiome Angle

The clinical use of urinary citramalic in functional and integrative settings rests largely on its presumed microbial origin. Reviews of organic acid testing describe citramalate as being once thought to be exclusive to yeast and anaerobic bacteria, and it is commonly grouped with markers used to screen for gut dysbiosis (an imbalance in the gut microbial community). A higher level in this framework is interpreted as suggesting more microbial production, often attributed to yeast overgrowth or shifts in anaerobic bacterial populations.

This interpretation is biologically plausible and is supported by descriptions in the metabolomics literature, but it has not been validated by large human studies measuring urinary citramalic before and after targeted treatment of specific microbes. So the marker is reasonable to track if you are investigating gut symptoms, but treat its meaning as a working hypothesis rather than a verdict.

When Results Can Be Misleading

A single urine organic acid measurement can be pushed around by several factors that have nothing to do with disease. The most important ones to know:

• Recent diet: organic acid concentrations in urine reflect what you have been eating and metabolizing in the hours before the sample. Fermented foods, large protein meals, and certain plant compounds can shift the profile temporarily.
• Sample concentration: because urinary citramalic is reported relative to creatinine, hydration and muscle mass both influence the ratio. A very dilute or very concentrated sample can distort the reading even when the underlying biology has not changed.
• Method differences between labs: organic acid panels rely on specialized chromatography and mass spectrometry techniques, and performance varies between laboratories. Comparing results from different labs is not always apples to apples.
• Recent intense exercise: acute exercise has been shown to produce widespread, short-term changes in urinary metabolites. A sample taken within a day or two of a hard workout may not reflect your usual state.

There is no published evidence on specific medications that artifactually raise or lower urinary citramalic without affecting the underlying microbial picture. If a result looks unexpected, the safer assumption is that diet, hydration, timing, or lab variability could be contributing, and a confirming sample under steadier conditions is worth getting before drawing conclusions.

Tracking Your Trend

With a research marker like this, a single number is even less informative than usual. What matters far more is your personal trend over time and how it moves in response to changes you make. Get a baseline measurement under typical conditions, ideally as part of a wider organic acid panel rather than in isolation. If you are starting a targeted intervention for gut symptoms or dysbiosis, retest in three to six months to see whether your number is moving in the expected direction. If you are simply curious about your baseline microbial activity, an annual check is a reasonable cadence.

A second sample taken under similar conditions also gives you a sense of your own day-to-day variability, which is essential before reading too much into a single high or low value. Treat the first reading as a starting point, not a diagnosis.

What to Do With an Unexpected Result

If your urinary citramalic comes back substantially outside the published reference range from your lab, the next steps depend on what you are actually trying to learn. The most useful workup is rarely about chasing one organic acid. It is about looking at the whole pattern and pairing it with how you feel.

• Look at the full organic acid panel together. Citramalic is most informative when interpreted alongside other markers of microbial activity, mitochondrial (cellular energy producing) function, and neurotransmitter (brain chemical messenger) metabolism on the same panel. A single elevated acid in isolation is much weaker evidence than a coherent multi-marker pattern.
• Pair with a direct microbiome assessment. A stool-based microbiome or pathogen panel can tell you which microbes are actually present, which is a more direct answer than inferring from urinary metabolites.
• Consider a clinician familiar with functional or integrative medicine. Because there are no formal guidelines for acting on this marker, working with a provider who routinely interprets organic acid panels is usually more productive than presenting the result to a clinician seeing it for the first time.
• Recheck before any major intervention. Confirm an unexpected result with a repeat sample under steady conditions before starting antimicrobials, restrictive diets, or extended supplement protocols based on it.